Werewolf Therapeutics Investors

20 investors on Angel Roster list Werewolf Therapeutics in their portfolio. Most are private equity firms and venture capital firms, the most common stage is Seed and the largest groups are based in the United States.

Investors are matched on the company name in their portfolio, so companies that share the name Werewolf Therapeutics can appear together.

Investors listed
20
With verified email
50%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 20 Werewolf Therapeutics investors

The most complete profiles first. Showing 20 of 20.

  • Christoph WestphalVerified

    Venture Capital, Founder, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology and 24 more

    Verified email available

  • Rich AldrichVerified

    Venture Capital, Founder, Private Equity Firm · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology and 23 more

    Verified email available

  • Brian GoodmanVerified

    Venture Capital, Private Equity Firm, Investment Partner · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • David DonabedianVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology and 23 more

    Verified email available

  • Luke EvninVerified

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • Shinichiro FuseVerified

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • Todd FoleyVerified

    Venture Capital, Private Equity Firm, Investment Partner · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • Ed Hurwitz

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, Protego Biopharma, InformedDNA, Mitobridge and 60 more

    Contact details available

  • Seiji M.

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Theolytics, Harpoon Therapeutics, Werewolf Therapeutics, NextCure and 7 more

    Contact details available

  • Stephen Curtis

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

  • Takaaki Ishii

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Theolytics, Harpoon Therapeutics, Werewolf Therapeutics, NextCure and 7 more

    Contact details available

  • Christiana Bardon M.D.

    Venture Capital, Private Equity Firm, Investment Partner · United States

    Health CareGeneticsInvestment ManagementLife Science

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

  • Lea Hachigian

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology and 23 more

    Contact details available

  • Leigh Zawel

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

  • Vinay Bhaskar

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

  • Jack GoldsteinVerified

    Private Equity Firm · United States

    Health CareLife ScienceInformation ServicesRobotics

    Portfolio: Helios Health, Werewolf Therapeutics, Revenue Solutions Inc, NeoGuide Systems

    Verified email available

  • Jeff WeberVerified

    Private Equity Firm · United States

    Health CareLife ScienceInformation ServicesRobotics

    Portfolio: Helios Health, Werewolf Therapeutics, Revenue Solutions Inc, NeoGuide Systems

    Verified email available

  • Thomas CampbellVerified

    Private Equity Firm · United States

    Health CareLife ScienceInformation ServicesRobotics

    Portfolio: Helios Health, Werewolf Therapeutics, Revenue Solutions Inc, NeoGuide Systems

    Verified email available

  • Andrew Campbell

    Private Equity Firm · United States

    Health CareLife ScienceInformation ServicesRobotics

    Portfolio: Helios Health, Werewolf Therapeutics, Revenue Solutions Inc, NeoGuide Systems

    Contact details available

  • Jerry Chernock

    Private Equity Firm · United States

    Health CareLife ScienceInformation ServicesRobotics

    Portfolio: Helios Health, Werewolf Therapeutics, Revenue Solutions Inc, NeoGuide Systems

    Contact details available

Frequently asked questions

How many Werewolf Therapeutics investors are on Angel Roster?

Angel Roster lists 20 Werewolf Therapeutics investors. 10 of them (50%) include a verified email address.

What types of investors are they?

The most common investor types are Private Equity Firms (16), Venture Capital Firms (15) and Investment Partner Investors (3). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Werewolf Therapeutics investors invest in?

Among those that list a stage, the most common are Seed (6).

Where are Werewolf Therapeutics investors based?

Most are based in the United States (20).

Which companies have Werewolf Therapeutics investors backed?

The most-backed portfolio companies among them are Twentyeight-Seven Therapeutics (13), Verastem Oncology (13), Mitobridge (13), Harpoon Therapeutics (11) and Orna Therapeutics (11).

How do I contact Werewolf Therapeutics investors?

Create a free Angel Roster account to search and filter all 20, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.